HCQ Fails as COVID-19 Post-Exposure Prophylaxis in HCPs

Incidence of COVID-19 did no longer vary severely amongst a community of mostly healthcare consultants receiving antimalarial hydroxychloroquine (HCQ) following publicity to the virus and other folks that did no longer, a pragmatic randomized trial came upon. There was as…